Glycosylation as a strategy to improve antibody-based therapeutics

Cited by (763)

Items 101–200 of 763

1. Continuous counter‐current chromatography for capture and polishing steps in biopharmaceutical production
   Fabian Steinebach, Thomas Müller-Späth, M. Morbidelli · 2016 · Biotechnology Journal
2. N-Glycosylation of Plant-produced Recombinant Proteins
   Dirk Bosch, Alexandra Castilho, Andreas Loos, A. Schots, Herta Steinkellner · 2013 · Current Pharmaceutical Design
3. Linkage-specific sialic acid derivatization for MALDI-TOF-MS profiling of IgG glycopeptides.
   N. de Haan, K. Reiding, Markus Haberger, D. Reusch, D. Falck, M. Wuhrer · 2015 · Analytical Chemistry
4. Glycoengineering of Antibodies for Modulating Functions
   Lai‐Xi Wang, Xin Tong, Chao Li, John P. Giddens, Tiezheng Li · 2019 · Annual Review of Biochemistry
5. Role of Fc Core Fucosylation in the Effector Function of IgG1 Antibodies
   Josée Golay, Alain E. Andrea, Irene Cattaneo · 2022 · Frontiers in Immunology
6. Fast analysis of recombinant monoclonal antibodies using IdeS proteolytic digestion and electrospray mass spectrometry.
   G. Chevreux, Nolwenn Tilly, N. Bihoreau · 2011 · Analytical Biochemistry
7. Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys
   Leabman, Maya K, Meng, Y Gloria, Kelley, Robert F, DeForge, Laura E, Cowan, Kyra J, Iyer, Suhasini · 2013 · mAbs
8. Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
   Manfred Wuhrer, Maurice H. J. Selman, Liam Andrew McDonnell, Tania Kümpfel, Tobias J Derfuss, Mohsen Khademi, Tomas P Olsson, Reinhard Hohlfeld, Edgar Meinl, Markus Krumbholz · 2015 · Journal of Neuroinflammation
9. The sweet tooth of biopharmaceuticals: Importance of recombinant protein glycosylation analysis
   Nico Lingg, Peiqing Zhang, Zhiwei Song, Muriel Bardor · 2012 · Biotechnology Journal
10. A method to identify trace sulfated IgG N-glycans as biomarkers for rheumatoid arthritis
    Jingrong Wang, Weina Gao, Rudolf Grimm, Shibo Jiang, Yong Qi Liang, Hua Ye, Zhanguo Li, Lee‐Fong Yau, Hao Huang, Ju Liu et al. · 2017 · Nature Communications
11. HILIC analysis of fluorescence-labeled N-glycans from recombinant biopharmaceuticals
    Melmer, Michael, Stangler, Thomas, Schiefermeier, Mark, Brunner, Werner, Toll, Hansjörg, Rupprechter, Alfred, Lindner, Wolfgang, Premstaller, Andreas · 2010 · Analytical and Bioanalytical Chemistry
12. Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity
    Laura A. VanBlargan, Leslie Goo, Theodore C. Pierson · 2016 · Microbiology and Molecular Biology Reviews
13. Multi-angle effector function analysis of human monoclonal IgG glycovariants
    Dashivets, Tetyana, Thomann, Marco, Rueger, Petra, Knaupp, Alexander, Buchner, Johannes, Schlothauer, Tilman · 2015 · PLOS ONE
14. Pharmacokinetics interactions of monoclonal antibodies.
    N. Ferri, S. Bellosta, L. Baldessin, D. Boccia, G. Racagni, A. Corsini · 2016 · Pharmacological Research
15. The role of differential IgG glycosylation in the interaction of antibodies with FcγRs in vivo
    Robert M. Anthony, Falk Nimmerjahn · 2010 · Current Opinion in Organ Transplantation
16. Recent Developments in Synthetic Carbohydrate‐Based Diagnostics, Vaccines, and Therapeutics
    Alberto Fernández‐Tejada, Francisco Javier Cañada, Jesús Jiménez‐Barbero · 2015 · Chemistry - A European Journal
17. Site-selective chemoenzymatic glycoengineering of Fab and Fc glycans of a therapeutic antibody
    John P. Giddens, Joseph V. Lomino, David J. DiLillo, Jeffrey V. Ravetch, Lai‐Xi Wang · 2018 · Proceedings of the National Academy of Sciences
18. Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy
    Sang Taek Jung, Tae Hyun Kang, William Kelton, George Georgiou · 2011 · Current Opinion in Biotechnology
19. Sialylation as an Important Regulator of Antibody Function
    Ravi Vattepu, Sunny Lyn Sneed, Robert M. Anthony · 2022 · Frontiers in Immunology
20. Antibody glycoengineering strategies in mammalian cells
    Wang, Qiong, Chung, Cheng‐Yu, Chough, Sandra, Betenbaugh, Michael J. · 2018 · Biotechnology and Bioengineering
21. Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G
    Einarsdottir, Helga K., Selman, Maurice H. J., Kapur, Rick, Scherjon, Sicco, Koeleman, Carolien A. M., Deelder, André M., van der Schoot, C. Ellen, Vidarsson, Gestur, Wuhrer, Manfred · 2013 · Glycoconjugate Journal
22. Cell-Free Gene Expression: Methods and Applications
    Andrew C. Hunt, Blake J. Rasor, Kosuke Seki, Holly M. Ekas, Katherine F. Warfel, Ashty S. Karim, Michael C. Jewett · 2024 · Chemical Reviews
23. Rational design of therapeutic mAbs against aggregation through protein engineering and incorporation of glycosylation motifs applied to bevacizumab
    Fabienne Courtois, Neeraj J. Agrawal, Timothy M. Lauer, Bernhardt L. Trout · 2015 · mAbs
24. Glycosylation of plasma IgG in colorectal cancer prognosis
    Evropi Τheodoratou, Kujtim Thaçi, Felix V. Agakov, Maria N Timofeeva, Jerko Štambuk, Maja Pučić‐Baković, Frano Vučković, Peter Orchard, Anna Agakova, Farhat V. N. Din et al. · 2016 · Scientific Reports
25. Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system
    Yi-Ren Xu, John Lee, Cuong Tran, Tyler H Heibeck, Willie D. Wang, Jun-Hao Yang, R. Stafford, Alexander R. Steiner, A. Sato, T. Hallam et al. · 2014 · mAbs
26. Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy
    Christian Kellner, Anna Otte, Elisa Cappuzzello, Katja Klausz, Matthias Peipp · 2017 · Transfusion Medicine and Hemotherapy
27. Critical comparison of MS and immunoassays for the bioanalysis of therapeutic antibodies.
    E. Ezan, F. Bitsch · 2009 · Bioanalysis
28. Glycosynthase Mutants of Endoglycosidase S2 Show Potent Transglycosylation Activity and Remarkably Relaxed Substrate Specificity for Antibody Glycosylation Remodeling
    Tiezheng Li, Xin Tong, Qiang Yang, John P. Giddens, Lai‐Xi Wang · 2016 · Journal of Biological Chemistry
29. Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology
    J. Berry, Ryan G. Gaudet · 2011 · New Biotechnology
30. Impact of cell culture media additives on IgG glycosylation produced in Chinese hamster ovary cells
    Janike Ehret, Martina Zimmermann, Thomas Eichhorn, Aline Zimmer · 2018 · Biotechnology and Bioengineering
31. Glycoengineering of antibody (Herceptin) through yeast expression and in vitro enzymatic glycosylation
    Chiu-Ping Liu, Tsung-I Tsai, Ting Cheng, Vidya S. Shivatare, Chung‐Yi Wu, Chung‐Yi Wu, Chi‐Huey Wong · 2018 · Proceedings of the National Academy of Sciences
32. Automation of High-Throughput Mass Spectrometry-Based Plasma N-Glycome Analysis with Linkage-Specific Sialic Acid Esterification.
    M. Bladergroen, K. Reiding, A. Hipgrave Ederveen, G. Vreeker, F. Clerc, S. Holst, A. Bondt, M. Wuhrer, Y. V. D. van der Burgt · 2015 · Journal of Proteome Research
33. Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions
    Algirdas Grevys, Malin Bern, Stian Foss, Diane Bryant Bratlie, Anders Riise Moen, Kristin Støen Gunnarsen, Audun Aase, Terje Einar Michaelsen, Inger Sandlie, Jan Terje Andersen · 2015 · The Journal of Immunology
34. Synthesis of Glycopolymers by Controlled Radical Polymerization Techniques and Their Applications
    Vimary Vázquez-Dorbatt, Juneyoung Lee, En-wei Lin, H. D. Maynard · 2012 · ChemBioChem
35. Increasing the activity of monoclonal antibody therapeutics by continuous chromatography (MCSGP)
    Thomas Müller-Späth, Martin Krättli, Lars Aumann, Guido Ströhlein, Massimo Morbidelli · 2010 · Biotechnology and Bioengineering
36. Glutamine-linked and Non-consensus Asparagine-linked Oligosaccharides Present in Human Recombinant Antibodies Define Novel Protein Glycosylation Motifs
    John F. Valliere-Douglass, C. Eakin, A. Wallace, Randal R Ketchem, Wesley Wang, M. Treuheit, A. Balland · 2010 · Journal of Biological Chemistry
37. Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications
    Bastiaan L. Duivelshof, Wim Jiskoot, Alain Beck, Jean‐Luc Veuthey, Davy Guillarme, Valentina D’Atri · 2019 · Analytica Chimica Acta
38. Bioprocessing of Recombinant CHO-K1, CHO-DG44, and CHO-S: CHO Expression Hosts Favor Either mAb Production or Biomass Synthesis
    David Reinhart, Lukas Damjanovic, Christian Kaisermayer, Wolfgang Sommeregger, Andreas Gili, Bernhard Gasselhuber, Andreas Castan, Patrick Mayrhofer, Clemens Grünwald‐Gruber, Renate Kunert · 2018 · Biotechnology Journal
39. Engineering hydrophobic protein-carbohydrate interactions to fine-tune monoclonal antibodies
    Yu, Xiaojie, Baruah, Kavitha, Harvey, David J., Vasiljevic, Snezana, Alonzi, Dominic S., Song, Byeong-Doo, Higgins, Matthew K., Bowden, Thomas A., Scanlan, Christopher N., Crispin, Max · 2013 · Journal of the American Chemical Society
40. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design
    José M. M. Caaveiro, Masato Kiyoshi, Kouhei Tsumoto · 2015 · Immunological Reviews
41. Optimal Synthetic Glycosylation of a Therapeutic Antibody
    Thomas B. Parsons, Weston B. Struwe, Joseph Gault, Keisuke Yamamoto, Thomas A. Taylor, Ritu Raj, Kim Wals, Shabaz Mohammed, Carol V. Robinson, Justin L. P. Benesch et al. · 2016 · Angewandte Chemie International Edition
42. Realizing the promise of chemical glycobiology
    Lai‐Xi Wang, Benjamin G. Davis · 2013 · Chemical Science
43. Therapeutic Antibodies Against Cancer
    Mark J. Adler, Dimiter Stanchev Dimitrov · 2012 · Hematology/Oncology Clinics of North America
44. Allergenicity of Carbohydrates and Their Role in Anaphylactic Events
    S. Commins, T. Platts-Mills · 2010 · Current Allergy and Asthma Reports
45. Fc gamma receptors: glycobiology and therapeutic prospects
    Jerrard M. Hayes, Mark R. Wormald, Pauline Mary Rudd, Gavin P. Davey · 2016 · Journal of Inflammation Research
46. Sweet but dangerous – the role of immunoglobulin G glycosylation in autoimmunity and inflammation
    Mona H. C. Biermann, Gloria Griffante, Malgorzata Justyna Podolska, Sebastian Boeltz, J Stürmer, Luis Enrique Munoz, Rostyslav O. Bilyy, Martin Herrmann i · 2016 · Lupus
47. Blood Plasma IgG Fc Glycans are Significantly Altered in Alzheimer's Disease and Progressive Mild Cognitive Impairment
    Susanna L. Lundström, Hongqian Yang, Yaroslav Lyutvinskiy, Dorothea Rutishauser, Sanna‐Kaisa Herukka, Hilkka S. Soininen, Roman A. Zubarev · 2013 · Journal of Alzheimer s Disease
48. Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity
    Whitney Shatz-Binder, Shan Chung, Bing Li, Brett Marshall, Max L. Tejada, Wilson Phung, Wendy N. Sandoval, Robert F. Kelley, Justin M. Scheer · 2013 · mAbs
49. Microheterogeneity of Recombinant Antibodies: Analytics and Functional Impact
    Beate Beyer, Manfred Schuster, Alois Jungbauer, Nico Lingg · 2017 · Biotechnology Journal
50. Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa
    Yoshitake Sakae, Tadashi Satoh, Hirokazu Yagi, Saeko Yanaka, Takumi Yamaguchi, Yuya Isoda, Shigeru Iida, Yuko Okamoto, Koichi Kato · 2017 · Scientific Reports
51. Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile
    Christine W. Bruggeman, Gillian Dekkers, Arthur E. H. Bentlage, Louise W. Treffers, Sietse Quirijn Nagelkerke, Suzanne N. Lissenberg‐Thunnissen, Carolien A. M. Koeleman, Manfred Wuhrer, Timo K. van den Berg, Theo Rispens et al. · 2017 · The Journal of Immunology
52. Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion
    Yi Wang, Xiaojuan Li, Yan-Hui Liu, Daisy Richardson, Huijuan Li, M. Shameem, Xiaoyu Yang · 2016 · mAbs
53. Tailoring recombinant protein quality by rational media design
    David Brühlmann, M. Jordan, J. Hemberger, M. Sauer, Matthieu Stettler, H. Broly · 2015 · Biotechnology progress (Print)
54. Generation and Comparative Characterization of Glycosylated and Aglycosylated Human IgG1 Antibodies
    Dmitrij Hristodorov, R. Fischer, Hannah Joerissen, B. Müller-Tiemann, H. Apeler, Lars Linden · 2013 · Molecular Biotechnology
55. Chemical and Structural Analysis of an Antibody Folding Intermediate Trapped during Glycan Biosynthesis
    Thomas A. Bowden, Kavitha Baruah, Charlotte H. Coles, David J. Harvey, Xiao-Jie Yu, B. Song, David I. Stuart, A. R. Aricescu, Christopher N. Scanlan, E. Y. Jones et al. · 2012 · Journal of the American Chemical Society
56. Analytical and Functional Aspects of Antibody Sialylation
    Johannes Stadlmann, Martin Pabst, Friedrich Altmann · 2010 · Journal of Clinical Immunology
57. Solubility, Stability, and Avidity of Recombinant Antibody Fragments Expressed in Microorganisms
    Tae Hyun Kang, Baik Lin Seong · 2020 · Frontiers in Microbiology
58. Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic Proteins
    Alison Marie Smith, Hugh Manoli, Stacey Jaw, Kimberley Frutoz, Alan L. Epstein, Leslie A. Khawli, Frank‐Peter Theil · 2016 · Journal of Immunology Research
59. Dopant Enriched Nitrogen Gas Combined with Sheathless Capillary Electrophoresis–Electrospray Ionization-Mass Spectrometry for Improved Sensitivity and Repeatability in Glycopeptide Analysis
    Kammeijer, Guinevere S. M., Kohler, Isabelle, Jansen, Bas C., Hensbergen, Paul J., Mayboroda, Oleg A., Falck, David, Wuhrer, Manfred · 2016 · Analytical Chemistry
60. Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics
    Chunpeng Yang, Xinyu Gao, Rui Gong · 2018 · Frontiers in Immunology
61. Molecular cloning, characterization, genomic organization and promoter analysis of the α1,6-fucosyltransferase gene (fut8) expressed in the rat hybridoma cell line YB2/0
    Béatrice Teylaert, Edwige Meurice, Marie Bobowski, Anne Harduin‐Lepers, Christine Gaucher, Alexandre Fontayne, Sylvie Jorieux, Philippe Delannoy · 2011 · BMC Biotechnology
62. The Humoral Response to HIV‐1: New Insights, Renewed Focus
    Galit Alter, Michael Anthony Moody · 2010 · The Journal of Infectious Diseases
63. Prospects from systems serology research
    Kelly B. Arnold, A. Chung · 2017 · Immunology
64. IgG cooperativity – Is there allostery? Implications for antibody functions and therapeutic antibody development
    Danlin Yang, Rachel Kroe‐Barrett, Sanjaya Singh, Christopher J. Roberts, Thomas Maxon Laue · 2017 · mAbs
65. GlycoFi's technology to control the glycosylation of recombinant therapeutic proteins
    Alain Beck, Olivier Cochet, Thierry Wurch · 2009 · Expert Opinion on Drug Discovery
66. EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans
    Jonathan Sjögren, E. Cosgrave, Maria Allhorn, Maria Nordgren, S. Björk, Fredrik Olsson, S. Fredriksson, M. Collin · 2015 · Glycobiology
67. Glycoengineered antibodies: towards the next-generation of immunotherapeutics
    Renato Mastrangeli, Wolf Palinsky, Horst Bierau · 2018 · Glycobiology
68. Automated High-Throughput Permethylation for Glycosylation Analysis of Biologics Using MALDI-TOF-MS.
    Archana Shubhakar, R. P. Kozak, K. Reiding, L. Royle, D. Spencer, D. Fernandes, M. Wuhrer · 2016 · Analytical Chemistry
69. Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functions
    Christian Kellner, Stefanie Derer, Thomas Valerius, Matthias Peipp · 2013 · Methods
70. Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid
    Yehuda, Sharon, Padler-Karavani, Vered · 2020 · Frontiers in Immunology
71. Antibody variable region engineering for improving cancer immunotherapy
    Hantao Lou, Xuetao Cao · 2022 · 癌症：英文版
72. Synthetic Glycobiology: Parts, Systems, and Applications
    Weston Kightlinger, Katherine F. Warfel, Matthew P. DeLisa, Michael C. Jewett · 2020 · ACS Synthetic Biology
73. Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
    Wei Li, Zhongyu Zhu, Weizao Chen, Yang Feng, Dimiter Stanchev Dimitrov · 2017 · Frontiers in Immunology
74. Molecular and functional analysis of monoclonal antibodies in support of biologics development
    Xin Wang, Zhiqiang An, Wenxin Luo, Ningshao Xia, Qinjian Zhao · 2017 · Protein & Cell
75. Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 Signaling
    Debra Hannah Josephs, Heather J. Bax, Tihomir S. Dodev, Mirella Georgouli, Mano Nakamura, Giulia Pellizzari, Louise Saul, Panagiotis Karagiannis, Anthony Cheung, Cecilia Herráiz et al. · 2017 · Cancer Research
76. With or Without Sugar? (A)glycosylation of Therapeutic Antibodies
    Dmitrij Hristodorov, Rainer Fischer, Lars Lindén · 2012 · Molecular Biotechnology
77. Coming together at the hinges: Therapeutic prospects of IgG3
    Thach H. Chu, Edward F. Patz, Margaret E. Ackerman · 2021 · mAbs
78. Rapid High Yield Production of Different Glycoforms of Ebola Virus Monoclonal Antibody
    Alexandra Castilho, Natasha Bohorova, Josephine Grass, Ognian Bohorov, Larry Zeitlin, Kevin J. Whaley, Friedrich Altmann, Herta Steinkellner · 2011 · PLoS ONE
79. The Immunogenicity of Biologic Therapies
    Sandra Garcês, Jocelyne Demengeot · 2017 · Current problems in dermatology
80. Main Quality Attributes of Monoclonal Antibodies and Effect of Cell Culture Components
    Fatemeh Torkashvand, Behrouz Vaziri · 2017 · Iranian Biomedical Journal
81. Endo-F3 Glycosynthase Mutants Enable Chemoenzymatic Synthesis of Core-fucosylated Triantennary Complex Type Glycopeptides and Glycoproteins*
    John P. Giddens, J. Lomino, M. Amin, Lai-Xi Wang · 2016 · Journal of Biological Chemistry
82. Human IgG is produced in a pro-form that requires clipping of C-terminal lysines for maximal complement activation
    Ewald T. J. van den Bremer, F. Beurskens, M. Voorhorst, P. Engelberts, R. D. de Jong, B. G. van der Boom, Erika M. Cook, M. Lindorfer, R. Taylor, P. V. van Berkel et al. · 2015 · mAbs
83. Quantitative Analysis of Immunoglobulin Subclasses and Subclass Specific Glycosylation by LC-MS-MRM in Liver Disease
    Wei Yuan, M. Sanda, Jing Wu, J. Koomen, Radoslav Goldman · 2015 · Journal of Proteomics
84. Chemoenzymatic Fc Glycosylation via Engineered Aldehyde Tags
    Elizabeth L. Smith, John P. Giddens, Anthony T. Iavarone, Kamil Godula, Lai‐Xi Wang, Carolyn Ruth Bertozzi · 2014 · Bioconjugate Chemistry
85. A Panel of IgG1 b12 Variants with Selectively Diminished or Enhanced Affinity for Fcγ Receptors To Define the Role of Effector Functions in Protection against HIV
    Brian Moldt, Niccole Schultz, D. Cameron Dunlop, Michael D. Alpert, Jackson Dean Harvey, David T. Evans, Pascal Poignard, Ann Jones Hessell, Dennis R. Burton · 2011 · Journal of Virology
86. Remarkable Transglycosylation Activity of Glycosynthase Mutants of Endo-D, an Endo-β-N-acetylglucosaminidase from Streptococcus pneumoniae*
    Shu Fan, Wei Huang, Lai-Xi Wang · 2012 · Journal of Biological Chemistry
87. HIC resolution of an IgG1 with an oxidized Trp in a complementarity determining region
    Daniel Boyd, Timothy Kaschak, Boxu Yan · 2011 · Journal of Chromatography B
88. Dynamics of immature mAb glycoform secretion during CHO cell culture: An integrated modelling framework
    Ioscani Jiménez del Val, Yuzhou Fan, Dietmar Weilguny · 2016 · Biotechnology Journal
89. Capillary Electrophoresis/Mass Spectrometry of APTS-Labeled Glycans for the Identification of Unknown Glycan Species in Capillary Electrophoresis/Laser-Induced Fluorescence Systems
    Svenja‐Catharina Bunz, Erdmann Rapp, Christian Neusüß · 2013 · Analytical Chemistry
90. Monoclonal antibody N-glycosylation profiling using capillary electrophoresis – Mass spectrometry: Assessment and method validation
    Giorgetti, Jérémie, D’Atri, Valentina, Canonge, Julie, Lechner, Antony, Guillarme, Davy, Colas, Olivier, Wagner-Rousset, Elsa, Beck, Alain, Leize-Wagner, Emmanuelle, François, Yannis-Nicolas · 2018 · Talanta
91. Controlling the time evolution of mAb N‐linked glycosylation ‐ Part II: Model‐based predictions
    T. Villiger, Ernesto Scibona, Matthieu Stettler, H. Broly, M. Morbidelli, M. Šoóš · 2016 · Biotechnology progress (Print)
92. Glycomic analysis using glycoprotein immobilization for glycan extraction
    Shuang Yang, Yan Li, Punit Shah, Hui Zhang · 2013 · Analytical Chemistry
93. Drug development: longer-lived proteins
    Stephan Kontos, Jeffrey A. Hubbell · 2012 · Chemical Society Reviews
94. Improving Immunotherapy Through Glycodesign
    Matthew J. Buettner, Sagar R Shah, Christopher T. Saeui, Ryan Ariss, Kevin J. Yarema · 2018 · Frontiers in Immunology
95. Advances in glycosylation-mediated cancer-targeted drug delivery
    Lulu Cai, Zhipeng Gu, Jian Zhong, Di Wen, Guojun Chen, He Lin, Jun Wu, Zhen Gu · 2018 · Drug Discovery Today
96. Transient Glyco-Engineering to Produce Recombinant IgA1 with Defined N- and O-Glycans in Plants
    Martina Dicker, Marc Tschofen, Daniel Maresch, Julia König-Beihammer, Paloma Juárez, Diego Orzáez, Friedrich Altmann, Herta Steinkellner, Richard Strasser · 2016 · Frontiers in Plant Science
97. Targeting the Fc receptor in autoimmune disease
    Xinrui Li, Robert P. Kimberly · 2014 · Expert Opinion on Therapeutic Targets
98. Selective Deactivation of Serum IgG: A General Strategy for the Enhancement of Monoclonal Antibody Receptor Interactions
    Kavitha Baruah, Thomas A. Bowden, Benjamin A. Krishna, Raymond Allen Dwek, Max Crispin, Christopher N. Scanlan · 2012 · Journal of Molecular Biology
99. Asparagine-linked Oligosaccharides Present on a Non-consensus Amino Acid Sequence in the CH1 Domain of Human Antibodies
    John F. Valliere-Douglass, P. Kodama, Mirna Mujacic, Lowell J. Brady, Wesley Wang, A. Wallace, B. Yan, Pranhitha Reddy, M. Treuheit, A. Balland · 2009 · Journal of Biological Chemistry
100. Glycosylation of IgG-Fc: a molecular perspective
     Masato Kiyoshi, Kouhei Tsumoto, Akiko Ishii‐Watabe, José M. M. Caaveiro · 2017 · International Immunology